Brief instructions for use of the Indian version of bosutinib generics

Bosutinib is an oral tablet indicated for the treatment of adult and pediatric patients 1 year and older with chronicPh+ chronic myeloid leukemia (CML), whether newly diagnosed or in patients who are resistant or intolerant to prior therapy. In addition, bosutinib is also an effective treatment option for adult patients with accelerated phase or blast phase Ph+ CML who are resistant or intolerant to previous treatments. Due to its remarkable efficacy, many patients have a medical need for this drug. However, higher selling prices have led patients to switch to generic drugs. However, the method of use is still unclear. This article will briefly describe the instructions for use of the Indian version of bosutinib generics.

1. Drug name

Drug name: Bosutinib (Bosutinib)

Product name:BOSUTRIS

2. Usage and dosage

1. Dosage:

Adult patients (newly diagnosed): The recommended starting dose is 400 mg once dailytake with food.

Adult patients (resistance or intolerance to previous treatment): The recommended dose is 500 mg once dailytake with food.

Pediatric patients (newly diagnosed): The recommended dose is300 mg/m² once daily with food.

Pediatric patients (resistance or intolerance to previous treatment): The recommended dose is400 mg/m², taken once daily with food.

Please note that the above dosage is for reference only, and the actual dosage needs to be determined based on the patient's specific condition and the doctor's recommendation. Doctors may adjust the dose based on patient tolerance, efficacy and other factors.

2. How to take: Bosutinib is an oral tablet and should be taken with food. Patients should strictly follow the doctor's instructions, take the medicine on time and in the right amount, and do not adjust the dosage or stop the medicine on their own.

3. Precautions

1. Liver function: Bosutinib may affect liver function. Patients should have liver function tests performed regularly before and during treatment. If abnormal liver function occurs, please inform your doctor promptly.

2. Cardiovascular system: Bosutinib may cause adverse reactions in the cardiovascular system, such as hypertension, bradycardia, etc. Patients should regularly monitor blood pressure, heart rate and other indicators and inform their doctor of any abnormal symptoms.

3. Drug interactions: Inform your doctor of all the drugs you are taking, including prescription drugs, over-the-counter drugs, Chinese medicines, vitamins, minerals, etc., to avoid possible drug interactions.

4. Storage: Please store Bosutinib in a dry, cool, ventilated place, away from direct sunlight and high temperature. Please ensure that the medicine is completely packaged and kept out of reach of children.

In short, bosutinib is a targeted drug for the treatment of chronic Ph+ chronic myeloid leukemia (CML). Before use, please read this instruction manual carefully and follow your doctor's recommendations for treatment. If you have any questions or discomfort, please consult your doctor promptly. Currently, the version produced by Mylan in India is priced at more than 1,000 per box. Patients should choose regular channels to purchase.